Viemed Healthcare (VMD)
(Delayed Data from NSDQ)
$7.33 USD
-0.07 (-0.95%)
Updated Sep 10, 2024 04:00 PM ET
After-Market: $7.32 -0.01 (-0.14%) 5:02 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$7.33 USD
-0.07 (-0.95%)
Updated Sep 10, 2024 04:00 PM ET
After-Market: $7.32 -0.01 (-0.14%) 5:02 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Can Viemed Healthcare, Inc. (VMD) Climb 112% to Reach the Level Wall Street Analysts Expect?
by Zacks Equity Research
The consensus price target hints at an 111.9% upside potential for Viemed Healthcare, Inc. (VMD). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Viemed Healthcare, Inc. (VMD) Lags Q3 Earnings Estimates
by Zacks Equity Research
Viemed Healthcare, Inc. (VMD) delivered earnings and revenue surprises of -20.00% and 5.34%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Viemed Healthcare, Inc. (VMD) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Viemed Healthcare, Inc. (VMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Viemed Healthcare, Inc. (VMD) Surpasses Q2 Earnings Estimates
by Zacks Equity Research
Viemed Healthcare, Inc. (VMD) delivered earnings and revenue surprises of 100.00% and -0.37%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Viemed Healthcare, Inc. (VMD) Q2 Earnings Expected to Decline
by Zacks Equity Research
Viemed Healthcare, Inc. (VMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Viemed Healthcare, Inc. (VMD) Q1 Earnings Top Estimates
by Zacks Equity Research
Viemed Healthcare, Inc. (VMD) delivered earnings and revenue surprises of 33.33% and -2.01%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?